nodes	percent_of_prediction	percent_of_DWPC	metapath
Etidronic acid—PTPRS—prostate gland—urinary bladder cancer	0.0771	0.25	CbGeAlD
Etidronic acid—ATP6V1A—prostate gland—urinary bladder cancer	0.0445	0.144	CbGeAlD
Etidronic acid—PTPRS—female reproductive system—urinary bladder cancer	0.0421	0.136	CbGeAlD
Etidronic acid—ATP6V1A—renal system—urinary bladder cancer	0.0303	0.0982	CbGeAlD
Etidronic acid—ATP6V1A—urethra—urinary bladder cancer	0.0298	0.0964	CbGeAlD
Etidronic acid—PTPRS—lymph node—urinary bladder cancer	0.0246	0.0797	CbGeAlD
Etidronic acid—ATP6V1A—female reproductive system—urinary bladder cancer	0.0243	0.0786	CbGeAlD
Etidronic acid—ATP6V1A—vagina—urinary bladder cancer	0.0219	0.0711	CbGeAlD
Etidronic acid—ATP6V1A—lymph node—urinary bladder cancer	0.0142	0.046	CbGeAlD
Etidronic acid—Risedronate—PTGS2—urinary bladder cancer	0.00758	0.529	CrCbGaD
Etidronic acid—Clodronate—PTGS2—urinary bladder cancer	0.00676	0.471	CrCbGaD
Etidronic acid—Fracture—Methotrexate—urinary bladder cancer	0.00537	0.00825	CcSEcCtD
Etidronic acid—Multiple fractures—Methotrexate—urinary bladder cancer	0.00537	0.00825	CcSEcCtD
Etidronic acid—Discomfort—Mitomycin—urinary bladder cancer	0.00531	0.00815	CcSEcCtD
Etidronic acid—Pruritus—Valrubicin—urinary bladder cancer	0.00529	0.00812	CcSEcCtD
Etidronic acid—Confusional state—Mitomycin—urinary bladder cancer	0.00519	0.00797	CcSEcCtD
Etidronic acid—Diarrhoea—Valrubicin—urinary bladder cancer	0.00511	0.00785	CcSEcCtD
Etidronic acid—Oesophagitis—Etoposide—urinary bladder cancer	0.00476	0.00731	CcSEcCtD
Etidronic acid—Vomiting—Valrubicin—urinary bladder cancer	0.00475	0.0073	CcSEcCtD
Etidronic acid—Rash maculo-papular—Etoposide—urinary bladder cancer	0.00474	0.00728	CcSEcCtD
Etidronic acid—Rash—Valrubicin—urinary bladder cancer	0.00471	0.00724	CcSEcCtD
Etidronic acid—Dermatitis—Valrubicin—urinary bladder cancer	0.00471	0.00723	CcSEcCtD
Etidronic acid—Headache—Valrubicin—urinary bladder cancer	0.00468	0.00719	CcSEcCtD
Etidronic acid—Amnesia—Fluorouracil—urinary bladder cancer	0.00464	0.00712	CcSEcCtD
Etidronic acid—Nausea—Valrubicin—urinary bladder cancer	0.00444	0.00682	CcSEcCtD
Etidronic acid—Amnesia—Cisplatin—urinary bladder cancer	0.0044	0.00675	CcSEcCtD
Etidronic acid—Osteoarthritis—Fluorouracil—urinary bladder cancer	0.00436	0.00669	CcSEcCtD
Etidronic acid—Pancytopenia—Thiotepa—urinary bladder cancer	0.00432	0.00664	CcSEcCtD
Etidronic acid—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00424	0.00652	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—LOXL4—urinary bladder cancer	0.00412	0.159	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transferrin endocytosis and recycling—TFRC—urinary bladder cancer	0.00388	0.15	CbGpPWpGaD
Etidronic acid—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00379	0.00582	CcSEcCtD
Etidronic acid—Pancytopenia—Gemcitabine—urinary bladder cancer	0.00364	0.00559	CcSEcCtD
Etidronic acid—Hallucination—Thiotepa—urinary bladder cancer	0.00363	0.00557	CcSEcCtD
Etidronic acid—Pancytopenia—Fluorouracil—urinary bladder cancer	0.00358	0.00549	CcSEcCtD
Etidronic acid—Diarrhoea—Mitomycin—urinary bladder cancer	0.00352	0.00541	CcSEcCtD
Etidronic acid—Pancytopenia—Cisplatin—urinary bladder cancer	0.00339	0.00521	CcSEcCtD
Etidronic acid—Glossitis—Methotrexate—urinary bladder cancer	0.00339	0.0052	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.00338	0.0052	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Gemcitabine—urinary bladder cancer	0.00335	0.00514	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Fluorouracil—urinary bladder cancer	0.00329	0.00505	CcSEcCtD
Etidronic acid—Vomiting—Mitomycin—urinary bladder cancer	0.00327	0.00503	CcSEcCtD
Etidronic acid—Rash—Mitomycin—urinary bladder cancer	0.00325	0.00498	CcSEcCtD
Etidronic acid—Dermatitis—Mitomycin—urinary bladder cancer	0.00324	0.00498	CcSEcCtD
Etidronic acid—Headache—Mitomycin—urinary bladder cancer	0.00322	0.00495	CcSEcCtD
Etidronic acid—Alopecia—Thiotepa—urinary bladder cancer	0.00322	0.00495	CcSEcCtD
Etidronic acid—Arthropathy—Epirubicin—urinary bladder cancer	0.00321	0.00493	CcSEcCtD
Etidronic acid—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00319	0.00489	CcSEcCtD
Etidronic acid—Erythema—Thiotepa—urinary bladder cancer	0.00317	0.00487	CcSEcCtD
Etidronic acid—Glossitis—Epirubicin—urinary bladder cancer	0.00317	0.00487	CcSEcCtD
Etidronic acid—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00313	0.00481	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—LOXL1—urinary bladder cancer	0.00312	0.121	CbGpPWpGaD
Etidronic acid—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.00312	0.00479	CcSEcCtD
Etidronic acid—Pancytopenia—Etoposide—urinary bladder cancer	0.00311	0.00477	CcSEcCtD
Etidronic acid—Nausea—Mitomycin—urinary bladder cancer	0.00306	0.0047	CcSEcCtD
Etidronic acid—Bone pain—Epirubicin—urinary bladder cancer	0.00305	0.00468	CcSEcCtD
Etidronic acid—Arthropathy—Doxorubicin—urinary bladder cancer	0.00297	0.00457	CcSEcCtD
Etidronic acid—Glossitis—Doxorubicin—urinary bladder cancer	0.00293	0.00451	CcSEcCtD
Etidronic acid—Anaemia—Thiotepa—urinary bladder cancer	0.00293	0.0045	CcSEcCtD
Etidronic acid—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.0029	0.00445	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.00289	0.00444	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.00286	0.00439	CcSEcCtD
Etidronic acid—Leukopenia—Thiotepa—urinary bladder cancer	0.00284	0.00436	CcSEcCtD
Etidronic acid—ATP6V1A—Iron uptake and transport—TFRC—urinary bladder cancer	0.00283	0.109	CbGpPWpGaD
Etidronic acid—Bone pain—Doxorubicin—urinary bladder cancer	0.00282	0.00433	CcSEcCtD
Etidronic acid—Agranulocytosis—Etoposide—urinary bladder cancer	0.00272	0.00418	CcSEcCtD
Etidronic acid—Alopecia—Gemcitabine—urinary bladder cancer	0.00271	0.00416	CcSEcCtD
Etidronic acid—Arthralgia—Thiotepa—urinary bladder cancer	0.0027	0.00415	CcSEcCtD
Etidronic acid—Cramps of lower extremities—Epirubicin—urinary bladder cancer	0.00268	0.00412	CcSEcCtD
Etidronic acid—Oesophagitis—Epirubicin—urinary bladder cancer	0.00267	0.0041	CcSEcCtD
Etidronic acid—Erythema—Gemcitabine—urinary bladder cancer	0.00267	0.0041	CcSEcCtD
Etidronic acid—Alopecia—Fluorouracil—urinary bladder cancer	0.00266	0.00409	CcSEcCtD
Etidronic acid—Rash maculo-papular—Epirubicin—urinary bladder cancer	0.00266	0.00408	CcSEcCtD
Etidronic acid—Erythema—Fluorouracil—urinary bladder cancer	0.00262	0.00403	CcSEcCtD
Etidronic acid—Confusional state—Thiotepa—urinary bladder cancer	0.00261	0.00401	CcSEcCtD
Etidronic acid—Infection—Thiotepa—urinary bladder cancer	0.00257	0.00395	CcSEcCtD
Etidronic acid—Alopecia—Cisplatin—urinary bladder cancer	0.00252	0.00388	CcSEcCtD
Etidronic acid—Erythema—Cisplatin—urinary bladder cancer	0.00249	0.00382	CcSEcCtD
Etidronic acid—Cramps of lower extremities—Doxorubicin—urinary bladder cancer	0.00248	0.00381	CcSEcCtD
Etidronic acid—Erythema multiforme—Etoposide—urinary bladder cancer	0.00247	0.0038	CcSEcCtD
Etidronic acid—Oesophagitis—Doxorubicin—urinary bladder cancer	0.00247	0.00379	CcSEcCtD
Etidronic acid—Anaemia—Gemcitabine—urinary bladder cancer	0.00247	0.00379	CcSEcCtD
Etidronic acid—Rash maculo-papular—Doxorubicin—urinary bladder cancer	0.00246	0.00377	CcSEcCtD
Etidronic acid—Flatulence—Cisplatin—urinary bladder cancer	0.00245	0.00376	CcSEcCtD
Etidronic acid—Anaemia—Fluorouracil—urinary bladder cancer	0.00242	0.00372	CcSEcCtD
Etidronic acid—Muscle spasms—Cisplatin—urinary bladder cancer	0.00239	0.00367	CcSEcCtD
Etidronic acid—Leukopenia—Gemcitabine—urinary bladder cancer	0.00239	0.00367	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00236	0.00362	CcSEcCtD
Etidronic acid—Leukopenia—Fluorouracil—urinary bladder cancer	0.00235	0.00361	CcSEcCtD
Etidronic acid—Paraesthesia—Thiotepa—urinary bladder cancer	0.00232	0.00357	CcSEcCtD
Etidronic acid—Alopecia—Etoposide—urinary bladder cancer	0.00231	0.00355	CcSEcCtD
Etidronic acid—Anaemia—Cisplatin—urinary bladder cancer	0.0023	0.00353	CcSEcCtD
Etidronic acid—Dyspepsia—Thiotepa—urinary bladder cancer	0.00228	0.0035	CcSEcCtD
Etidronic acid—Arthralgia—Gemcitabine—urinary bladder cancer	0.00227	0.00349	CcSEcCtD
Etidronic acid—Osteoarthritis—Methotrexate—urinary bladder cancer	0.00227	0.00348	CcSEcCtD
Etidronic acid—Discomfort—Gemcitabine—urinary bladder cancer	0.00224	0.00345	CcSEcCtD
Etidronic acid—Leukopenia—Cisplatin—urinary bladder cancer	0.00223	0.00342	CcSEcCtD
Etidronic acid—Constipation—Thiotepa—urinary bladder cancer	0.00221	0.0034	CcSEcCtD
Etidronic acid—Discomfort—Fluorouracil—urinary bladder cancer	0.00221	0.00339	CcSEcCtD
Etidronic acid—Muscle spasms—Etoposide—urinary bladder cancer	0.00219	0.00336	CcSEcCtD
Etidronic acid—Infection—Gemcitabine—urinary bladder cancer	0.00216	0.00332	CcSEcCtD
Etidronic acid—Confusional state—Fluorouracil—urinary bladder cancer	0.00216	0.00332	CcSEcCtD
Etidronic acid—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00213	0.00328	CcSEcCtD
Etidronic acid—Infection—Fluorouracil—urinary bladder cancer	0.00213	0.00327	CcSEcCtD
Etidronic acid—Osteoarthritis—Epirubicin—urinary bladder cancer	0.00212	0.00326	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00212	0.00325	CcSEcCtD
Etidronic acid—Anaemia—Etoposide—urinary bladder cancer	0.00211	0.00323	CcSEcCtD
Etidronic acid—Discomfort—Cisplatin—urinary bladder cancer	0.00209	0.00321	CcSEcCtD
Etidronic acid—Urticaria—Thiotepa—urinary bladder cancer	0.00206	0.00316	CcSEcCtD
Etidronic acid—Abdominal pain—Thiotepa—urinary bladder cancer	0.00205	0.00314	CcSEcCtD
Etidronic acid—Leukopenia—Etoposide—urinary bladder cancer	0.00204	0.00313	CcSEcCtD
Etidronic acid—Infection—Cisplatin—urinary bladder cancer	0.00202	0.0031	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00198	0.00305	CcSEcCtD
Etidronic acid—Osteoarthritis—Doxorubicin—urinary bladder cancer	0.00196	0.00301	CcSEcCtD
Etidronic acid—Asthma—Methotrexate—urinary bladder cancer	0.00196	0.00301	CcSEcCtD
Etidronic acid—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00196	0.003	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00195	0.003	CcSEcCtD
Etidronic acid—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00192	0.00295	CcSEcCtD
Etidronic acid—Discomfort—Etoposide—urinary bladder cancer	0.00192	0.00294	CcSEcCtD
Etidronic acid—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00191	0.00293	CcSEcCtD
Etidronic acid—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00188	0.00289	CcSEcCtD
Etidronic acid—Gastritis—Epirubicin—urinary bladder cancer	0.00188	0.00288	CcSEcCtD
Etidronic acid—Confusional state—Etoposide—urinary bladder cancer	0.00187	0.00288	CcSEcCtD
Etidronic acid—Constipation—Gemcitabine—urinary bladder cancer	0.00186	0.00286	CcSEcCtD
Etidronic acid—Pancytopenia—Methotrexate—urinary bladder cancer	0.00186	0.00286	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00185	0.00284	CcSEcCtD
Etidronic acid—Infection—Etoposide—urinary bladder cancer	0.00185	0.00284	CcSEcCtD
Etidronic acid—Asthma—Epirubicin—urinary bladder cancer	0.00183	0.00282	CcSEcCtD
Etidronic acid—Pruritus—Thiotepa—urinary bladder cancer	0.00183	0.00281	CcSEcCtD
Etidronic acid—Paraesthesia—Cisplatin—urinary bladder cancer	0.00182	0.0028	CcSEcCtD
Etidronic acid—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00179	0.00276	CcSEcCtD
Etidronic acid—Diarrhoea—Thiotepa—urinary bladder cancer	0.00177	0.00272	CcSEcCtD
Etidronic acid—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00176	0.00271	CcSEcCtD
Etidronic acid—Pancytopenia—Epirubicin—urinary bladder cancer	0.00174	0.00267	CcSEcCtD
Etidronic acid—Gastritis—Doxorubicin—urinary bladder cancer	0.00174	0.00267	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.00173	0.00266	CcSEcCtD
Etidronic acid—Urticaria—Fluorouracil—urinary bladder cancer	0.0017	0.00261	CcSEcCtD
Etidronic acid—Asthma—Doxorubicin—urinary bladder cancer	0.0017	0.0026	CcSEcCtD
Etidronic acid—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00167	0.00257	CcSEcCtD
Etidronic acid—Paraesthesia—Etoposide—urinary bladder cancer	0.00167	0.00256	CcSEcCtD
Etidronic acid—Vomiting—Thiotepa—urinary bladder cancer	0.00165	0.00253	CcSEcCtD
Etidronic acid—Rash—Thiotepa—urinary bladder cancer	0.00163	0.00251	CcSEcCtD
Etidronic acid—Dermatitis—Thiotepa—urinary bladder cancer	0.00163	0.0025	CcSEcCtD
Etidronic acid—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00163	0.0025	CcSEcCtD
Etidronic acid—Headache—Thiotepa—urinary bladder cancer	0.00162	0.00249	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00162	0.00249	CcSEcCtD
Etidronic acid—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00161	0.00247	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.0016	0.00246	CcSEcCtD
Etidronic acid—Constipation—Etoposide—urinary bladder cancer	0.00159	0.00244	CcSEcCtD
Etidronic acid—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00158	0.00242	CcSEcCtD
Etidronic acid—Pruritus—Gemcitabine—urinary bladder cancer	0.00154	0.00237	CcSEcCtD
Etidronic acid—Nausea—Thiotepa—urinary bladder cancer	0.00154	0.00236	CcSEcCtD
Etidronic acid—Feeling abnormal—Etoposide—urinary bladder cancer	0.00153	0.00235	CcSEcCtD
Etidronic acid—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00153	0.00234	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00152	0.00234	CcSEcCtD
Etidronic acid—Pruritus—Fluorouracil—urinary bladder cancer	0.00151	0.00233	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.0015	0.0023	CcSEcCtD
Etidronic acid—Hypersensitivity—Cisplatin—urinary bladder cancer	0.0015	0.0023	CcSEcCtD
Etidronic acid—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00149	0.00229	CcSEcCtD
Etidronic acid—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00148	0.00228	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.00148	0.00228	CcSEcCtD
Etidronic acid—Urticaria—Etoposide—urinary bladder cancer	0.00148	0.00227	CcSEcCtD
Etidronic acid—Abdominal pain—Etoposide—urinary bladder cancer	0.00147	0.00226	CcSEcCtD
Etidronic acid—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00146	0.00225	CcSEcCtD
Etidronic acid—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00141	0.00217	CcSEcCtD
Etidronic acid—Diarrhoea—Cisplatin—urinary bladder cancer	0.00139	0.00213	CcSEcCtD
Etidronic acid—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00139	0.00213	CcSEcCtD
Etidronic acid—Alopecia—Methotrexate—urinary bladder cancer	0.00139	0.00213	CcSEcCtD
Etidronic acid—Vomiting—Gemcitabine—urinary bladder cancer	0.00138	0.00213	CcSEcCtD
Etidronic acid—Rash—Gemcitabine—urinary bladder cancer	0.00137	0.00211	CcSEcCtD
Etidronic acid—Dermatitis—Gemcitabine—urinary bladder cancer	0.00137	0.00211	CcSEcCtD
Etidronic acid—Hypersensitivity—Etoposide—urinary bladder cancer	0.00137	0.0021	CcSEcCtD
Etidronic acid—Erythema—Methotrexate—urinary bladder cancer	0.00136	0.0021	CcSEcCtD
Etidronic acid—Headache—Gemcitabine—urinary bladder cancer	0.00136	0.0021	CcSEcCtD
Etidronic acid—Vomiting—Fluorouracil—urinary bladder cancer	0.00136	0.00209	CcSEcCtD
Etidronic acid—Rash—Fluorouracil—urinary bladder cancer	0.00135	0.00207	CcSEcCtD
Etidronic acid—Dermatitis—Fluorouracil—urinary bladder cancer	0.00135	0.00207	CcSEcCtD
Etidronic acid—Headache—Fluorouracil—urinary bladder cancer	0.00134	0.00206	CcSEcCtD
Etidronic acid—Pruritus—Etoposide—urinary bladder cancer	0.00132	0.00202	CcSEcCtD
Etidronic acid—Alopecia—Epirubicin—urinary bladder cancer	0.0013	0.00199	CcSEcCtD
Etidronic acid—Nausea—Gemcitabine—urinary bladder cancer	0.00129	0.00199	CcSEcCtD
Etidronic acid—Vomiting—Cisplatin—urinary bladder cancer	0.00129	0.00198	CcSEcCtD
Etidronic acid—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00128	0.00197	CcSEcCtD
Etidronic acid—Rash—Cisplatin—urinary bladder cancer	0.00128	0.00197	CcSEcCtD
Etidronic acid—Dermatitis—Cisplatin—urinary bladder cancer	0.00128	0.00196	CcSEcCtD
Etidronic acid—Erythema—Epirubicin—urinary bladder cancer	0.00128	0.00196	CcSEcCtD
Etidronic acid—Diarrhoea—Etoposide—urinary bladder cancer	0.00127	0.00195	CcSEcCtD
Etidronic acid—Nausea—Fluorouracil—urinary bladder cancer	0.00127	0.00195	CcSEcCtD
Etidronic acid—Anaemia—Methotrexate—urinary bladder cancer	0.00126	0.00194	CcSEcCtD
Etidronic acid—Flatulence—Epirubicin—urinary bladder cancer	0.00126	0.00193	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—TSC1—urinary bladder cancer	0.00126	0.0485	CbGpPWpGaD
Etidronic acid—Muscle spasms—Epirubicin—urinary bladder cancer	0.00123	0.00189	CcSEcCtD
Etidronic acid—Leukopenia—Methotrexate—urinary bladder cancer	0.00122	0.00188	CcSEcCtD
Etidronic acid—Nausea—Cisplatin—urinary bladder cancer	0.00121	0.00185	CcSEcCtD
Etidronic acid—Alopecia—Doxorubicin—urinary bladder cancer	0.0012	0.00184	CcSEcCtD
Etidronic acid—Vomiting—Etoposide—urinary bladder cancer	0.00118	0.00182	CcSEcCtD
Etidronic acid—Erythema—Doxorubicin—urinary bladder cancer	0.00118	0.00182	CcSEcCtD
Etidronic acid—Anaemia—Epirubicin—urinary bladder cancer	0.00118	0.00181	CcSEcCtD
Etidronic acid—Rash—Etoposide—urinary bladder cancer	0.00117	0.0018	CcSEcCtD
Etidronic acid—Dermatitis—Etoposide—urinary bladder cancer	0.00117	0.0018	CcSEcCtD
Etidronic acid—Headache—Etoposide—urinary bladder cancer	0.00116	0.00179	CcSEcCtD
Etidronic acid—Flatulence—Doxorubicin—urinary bladder cancer	0.00116	0.00179	CcSEcCtD
Etidronic acid—Arthralgia—Methotrexate—urinary bladder cancer	0.00116	0.00178	CcSEcCtD
Etidronic acid—Discomfort—Methotrexate—urinary bladder cancer	0.00115	0.00176	CcSEcCtD
Etidronic acid—Leukopenia—Epirubicin—urinary bladder cancer	0.00114	0.00176	CcSEcCtD
Etidronic acid—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00114	0.00175	CcSEcCtD
Etidronic acid—Confusional state—Methotrexate—urinary bladder cancer	0.00112	0.00172	CcSEcCtD
Etidronic acid—Infection—Methotrexate—urinary bladder cancer	0.00111	0.0017	CcSEcCtD
Etidronic acid—Nausea—Etoposide—urinary bladder cancer	0.0011	0.0017	CcSEcCtD
Etidronic acid—Anaemia—Doxorubicin—urinary bladder cancer	0.00109	0.00168	CcSEcCtD
Etidronic acid—Arthralgia—Epirubicin—urinary bladder cancer	0.00109	0.00167	CcSEcCtD
Etidronic acid—Discomfort—Epirubicin—urinary bladder cancer	0.00107	0.00165	CcSEcCtD
Etidronic acid—Leukopenia—Doxorubicin—urinary bladder cancer	0.00106	0.00162	CcSEcCtD
Etidronic acid—Confusional state—Epirubicin—urinary bladder cancer	0.00105	0.00161	CcSEcCtD
Etidronic acid—Infection—Epirubicin—urinary bladder cancer	0.00104	0.00159	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00101	0.00156	CcSEcCtD
Etidronic acid—Arthralgia—Doxorubicin—urinary bladder cancer	0.00101	0.00155	CcSEcCtD
Etidronic acid—Paraesthesia—Methotrexate—urinary bladder cancer	0.001	0.00154	CcSEcCtD
Etidronic acid—Discomfort—Doxorubicin—urinary bladder cancer	0.000994	0.00153	CcSEcCtD
Etidronic acid—Dyspepsia—Methotrexate—urinary bladder cancer	0.00098	0.00151	CcSEcCtD
Etidronic acid—Confusional state—Doxorubicin—urinary bladder cancer	0.000972	0.00149	CcSEcCtD
Etidronic acid—Infection—Doxorubicin—urinary bladder cancer	0.000958	0.00147	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00095	0.00146	CcSEcCtD
Etidronic acid—Paraesthesia—Epirubicin—urinary bladder cancer	0.000936	0.00144	CcSEcCtD
Etidronic acid—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000918	0.00141	CcSEcCtD
Etidronic acid—Dyspepsia—Epirubicin—urinary bladder cancer	0.000917	0.00141	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000911	0.0014	CcSEcCtD
Etidronic acid—Constipation—Epirubicin—urinary bladder cancer	0.000891	0.00137	CcSEcCtD
Etidronic acid—Urticaria—Methotrexate—urinary bladder cancer	0.000885	0.00136	CcSEcCtD
Etidronic acid—Abdominal pain—Methotrexate—urinary bladder cancer	0.00088	0.00135	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000879	0.00135	CcSEcCtD
Etidronic acid—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000866	0.00133	CcSEcCtD
Etidronic acid—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000859	0.00132	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000857	0.0331	CbGpPWpGaD
Etidronic acid—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000852	0.00131	CcSEcCtD
Etidronic acid—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000849	0.0013	CcSEcCtD
Etidronic acid—Urticaria—Epirubicin—urinary bladder cancer	0.000828	0.00127	CcSEcCtD
Etidronic acid—Constipation—Doxorubicin—urinary bladder cancer	0.000825	0.00127	CcSEcCtD
Etidronic acid—Abdominal pain—Epirubicin—urinary bladder cancer	0.000824	0.00127	CcSEcCtD
Etidronic acid—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000821	0.00126	CcSEcCtD
Etidronic acid—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000795	0.00122	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000789	0.00121	CcSEcCtD
Etidronic acid—Pruritus—Methotrexate—urinary bladder cancer	0.000788	0.00121	CcSEcCtD
Etidronic acid—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000768	0.00118	CcSEcCtD
Etidronic acid—Urticaria—Doxorubicin—urinary bladder cancer	0.000766	0.00118	CcSEcCtD
Etidronic acid—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000762	0.00117	CcSEcCtD
Etidronic acid—Diarrhoea—Methotrexate—urinary bladder cancer	0.000762	0.00117	CcSEcCtD
Etidronic acid—Pruritus—Epirubicin—urinary bladder cancer	0.000737	0.00113	CcSEcCtD
Etidronic acid—Diarrhoea—Epirubicin—urinary bladder cancer	0.000713	0.0011	CcSEcCtD
Etidronic acid—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000711	0.00109	CcSEcCtD
Etidronic acid—Vomiting—Methotrexate—urinary bladder cancer	0.000708	0.00109	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—FGFR3—urinary bladder cancer	0.000704	0.0272	CbGpPWpGaD
Etidronic acid—Rash—Methotrexate—urinary bladder cancer	0.000702	0.00108	CcSEcCtD
Etidronic acid—Dermatitis—Methotrexate—urinary bladder cancer	0.000702	0.00108	CcSEcCtD
Etidronic acid—Headache—Methotrexate—urinary bladder cancer	0.000698	0.00107	CcSEcCtD
Etidronic acid—Pruritus—Doxorubicin—urinary bladder cancer	0.000682	0.00105	CcSEcCtD
Etidronic acid—Vomiting—Epirubicin—urinary bladder cancer	0.000663	0.00102	CcSEcCtD
Etidronic acid—Nausea—Methotrexate—urinary bladder cancer	0.000662	0.00102	CcSEcCtD
Etidronic acid—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00066	0.00101	CcSEcCtD
Etidronic acid—Rash—Epirubicin—urinary bladder cancer	0.000657	0.00101	CcSEcCtD
Etidronic acid—Dermatitis—Epirubicin—urinary bladder cancer	0.000657	0.00101	CcSEcCtD
Etidronic acid—Headache—Epirubicin—urinary bladder cancer	0.000653	0.001	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—CDH1—urinary bladder cancer	0.000631	0.0244	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00062	0.0239	CbGpPWpGaD
Etidronic acid—Nausea—Epirubicin—urinary bladder cancer	0.000619	0.000951	CcSEcCtD
Etidronic acid—Vomiting—Doxorubicin—urinary bladder cancer	0.000613	0.000942	CcSEcCtD
Etidronic acid—Rash—Doxorubicin—urinary bladder cancer	0.000608	0.000934	CcSEcCtD
Etidronic acid—Dermatitis—Doxorubicin—urinary bladder cancer	0.000608	0.000933	CcSEcCtD
Etidronic acid—Headache—Doxorubicin—urinary bladder cancer	0.000604	0.000928	CcSEcCtD
Etidronic acid—Nausea—Doxorubicin—urinary bladder cancer	0.000573	0.00088	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000505	0.0195	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—GSTO2—urinary bladder cancer	0.000479	0.0185	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—MMP9—urinary bladder cancer	0.000457	0.0176	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SLC19A1—urinary bladder cancer	0.000373	0.0144	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PRSS3—urinary bladder cancer	0.000363	0.014	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HDAC4—urinary bladder cancer	0.000347	0.0134	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000341	0.0132	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—KRAS—urinary bladder cancer	0.000329	0.0127	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—HRAS—urinary bladder cancer	0.000279	0.0108	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—LIG1—urinary bladder cancer	0.000275	0.0106	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HDAC4—urinary bladder cancer	0.000243	0.00938	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ENO2—urinary bladder cancer	0.00021	0.00811	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GLI1—urinary bladder cancer	0.000203	0.00786	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—RBX1—urinary bladder cancer	0.000199	0.00769	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—JAG1—urinary bladder cancer	0.000178	0.00688	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.00016	0.00617	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—RBX1—urinary bladder cancer	0.000139	0.00538	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TSC1—urinary bladder cancer	0.000131	0.00506	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NCOR1—urinary bladder cancer	0.00013	0.00501	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—JAG1—urinary bladder cancer	0.000125	0.00482	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ERCC2—urinary bladder cancer	0.000122	0.00471	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MTHFR—urinary bladder cancer	0.000115	0.00443	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—TERT—urinary bladder cancer	0.000114	0.00442	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—FGFR3—urinary bladder cancer	0.000105	0.00405	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—S100B—urinary bladder cancer	0.000101	0.0039	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NCOR1—urinary bladder cancer	9.08e-05	0.00351	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CREBBP—urinary bladder cancer	8.93e-05	0.00345	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—RHOA—urinary bladder cancer	8.08e-05	0.00312	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TERT—urinary bladder cancer	8.01e-05	0.00309	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ERBB2—urinary bladder cancer	7.48e-05	0.00289	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FGFR3—urinary bladder cancer	7.35e-05	0.00284	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PTGS2—urinary bladder cancer	7.31e-05	0.00283	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ESR1—urinary bladder cancer	7.14e-05	0.00276	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CDKN1A—urinary bladder cancer	6.39e-05	0.00247	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PTEN—urinary bladder cancer	6.38e-05	0.00246	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CREBBP—urinary bladder cancer	6.25e-05	0.00242	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IGF1—urinary bladder cancer	6.18e-05	0.00239	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—EP300—urinary bladder cancer	6.08e-05	0.00235	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SRC—urinary bladder cancer	5.91e-05	0.00228	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—RHOA—urinary bladder cancer	5.66e-05	0.00219	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MYC—urinary bladder cancer	5.3e-05	0.00205	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ERBB2—urinary bladder cancer	5.24e-05	0.00202	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—EGFR—urinary bladder cancer	5.18e-05	0.002	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCL8—urinary bladder cancer	4.97e-05	0.00192	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—KRAS—urinary bladder cancer	4.9e-05	0.00189	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL2—urinary bladder cancer	4.75e-05	0.00183	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CCND1—urinary bladder cancer	4.63e-05	0.00179	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MMP9—urinary bladder cancer	4.49e-05	0.00174	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CDKN1A—urinary bladder cancer	4.48e-05	0.00173	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PTEN—urinary bladder cancer	4.47e-05	0.00173	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EP300—urinary bladder cancer	4.26e-05	0.00165	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HRAS—urinary bladder cancer	4.16e-05	0.00161	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SRC—urinary bladder cancer	4.14e-05	0.0016	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MYC—urinary bladder cancer	3.71e-05	0.00143	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EGFR—urinary bladder cancer	3.63e-05	0.0014	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—KRAS—urinary bladder cancer	3.43e-05	0.00132	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TP53—urinary bladder cancer	3.05e-05	0.00118	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HRAS—urinary bladder cancer	2.92e-05	0.00113	CbGpPWpGaD
